BDBM50136037 1-(4-Butoxy-phenyl)-1H-imidazole::CHEMBL112532

SMILES: CCCCOc1ccc(cc1)-n1ccnc1

InChI Key: InChIKey=QJWFZZZHWWOBNM-UHFFFAOYSA-N

Data: 10 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50136037   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cytochrome P450 2D6 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	460	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2D6				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 3A4 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	348	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 3A4				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 1A2 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 1A2				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 2C9 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	96	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2C9				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 2C9 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	96	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co, Ltd Curated by ChEMBL					Assay Description Concentration required to inhibit cytochrome P450 2C9.				J Med Chem 46: 5416-27 (2003) Article DOI: 10.1021/jm020557k BindingDB Entry DOI: 10.7270/Q2QF8S96
					More data for this Ligand-Target Pair
Cytochrome P450 2C19 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co, Ltd Curated by ChEMBL					Assay Description Concentration required to inhibit cytochrome P450 19A1.				J Med Chem 46: 5416-27 (2003) Article DOI: 10.1021/jm020557k BindingDB Entry DOI: 10.7270/Q2QF8S96
					More data for this Ligand-Target Pair
Cytochrome P450 3A4 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	348	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co, Ltd Curated by ChEMBL					Assay Description Concentration required to inhibit cytochrome P450 3A4.				J Med Chem 46: 5416-27 (2003) Article DOI: 10.1021/jm020557k BindingDB Entry DOI: 10.7270/Q2QF8S96
					More data for this Ligand-Target Pair
Cytochrome P450 1A2 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co, Ltd Curated by ChEMBL					Assay Description Concentration required to inhibit cytochrome P450 1A2.				J Med Chem 46: 5416-27 (2003) Article DOI: 10.1021/jm020557k BindingDB Entry DOI: 10.7270/Q2QF8S96
					More data for this Ligand-Target Pair
Cytochrome P450 2D6 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	460	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co, Ltd Curated by ChEMBL					Assay Description Concentration required to inhibit cytochrome P450 2D6.				J Med Chem 46: 5416-27 (2003) Article DOI: 10.1021/jm020557k BindingDB Entry DOI: 10.7270/Q2QF8S96
					More data for this Ligand-Target Pair
Cytochrome P450 2C19 (Homo sapiens (Human))	BDBM50136037 (1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532) Show SMILES CCCCOc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2C19				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair